rererence product marketed only in some members states [Design Issues]

posted by ElMaestro  – Denmark, 2016-03-09 14:48 (3760 d 01:34 ago) – Posting: # 16079
Views: 7,262

Hi Sanjeith K,

in your case I would lean on directive 2001/83 §10.2b if we are talking IR:
" ‘generic medicinal product’ shall mean a medicinal product which has the same qualitative and quantitative composition in active substances and the same pharmaceutical form as the reference medicinal product (...) The various immediate-release oral pharmaceutical forms shall be considered to be one and the same pharmaceutical form."

- which means: try and find a immediate release tablet if you can.
If your formulation is the MR version then of course this is meaningless.

Forget about using a Canadian ref. in EU.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
129 visitors (0 registered, 129 guests [including 13 identified bots]).
Forum time: 17:23 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5